Division of Nephrology and Hypertension, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.
Int Urol Nephrol. 2013 Aug;45(4):1079-90. doi: 10.1007/s11255-012-0208-y. Epub 2012 Jun 9.
The optimal target for glycemic control has not been established for diabetic maintenance hemodialysis (MHD) patients.
A 6-year cohort (October 2001- December 2006) of 347 diabetic MHD patients with HbA1c data was examined for associations between HbA1c and mortality. Death hazard ratios (HR) were estimated using Cox regressions and cubic splines.
In these 347 patients (age, 59 ± 11 years; 49 % women; 28 % African Americans; and 55 % Hispanics), each 0.5 % decline in HbA1c below 6 % was associated with a 4.7 times higher death risk (HR = 4.7; 95 % CI 1.7-12.7) in the fully adjusted model. Factors associated with lower HbA1c levels (<6 % compared to 6-7 %) were: Hispanic ethnicity (OR = 2.9; 95 % CI 1.1-7.9), higher mid-arm muscle circumstance (OR = 1.1; 95 % CI 1.0-1.3), higher total iron-binding capacity (OR = 1.03; 95 % CI 1.01-1.05), and higher iron saturation ratio (OR = 1.14; 95 % CI 1.03-1.26). HbA1c levels >7 % showed a consistent trend toward elevated mortality risk (HR = 1.18; 95 % CI 0.99-1.41) after multivariate adjustment.
In diabetic MHD patients with burnt-out diabetes, characterized by HbA1c <6 %, even lower HbA1c levels are associated with significantly higher death risk. Additional studies are needed to determine the optimal target for HbA1c levels in different subgroups of diabetic MHD patients.
对于糖尿病维持性血液透析(MHD)患者,尚未确定血糖控制的最佳目标。
对 347 例有 HbA1c 数据的糖尿病 MHD 患者进行了一项为期 6 年的队列研究(2001 年 10 月至 2006 年 12 月),以研究 HbA1c 与死亡率之间的关系。使用 Cox 回归和三次样条估计死亡风险比(HR)。
在这 347 例患者(年龄 59 ± 11 岁;49%为女性;28%为非裔美国人;55%为西班牙裔)中,HbA1c 每降低 0.5%,在充分调整的模型中死亡风险增加 4.7 倍(HR = 4.7;95%CI 1.7-12.7)。与 HbA1c 水平较低(<6% 与 6-7% 相比)相关的因素包括:西班牙裔种族(OR = 2.9;95%CI 1.1-7.9)、更高的上臂中部肌肉围度(OR = 1.1;95%CI 1.0-1.3)、更高的总铁结合能力(OR = 1.03;95%CI 1.01-1.05)和更高的铁饱和度比(OR = 1.14;95%CI 1.03-1.26)。在多变量调整后,HbA1c 水平>7% 也显示出死亡风险增加的趋势(HR = 1.18;95%CI 0.99-1.41)。
在糖尿病 MHD 患者中,对于已经出现糖尿病衰竭(HbA1c <6%)的患者,即使 HbA1c 水平更低,也与更高的死亡风险显著相关。需要进一步的研究来确定不同亚组糖尿病 MHD 患者的 HbA1c 水平的最佳目标。